Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your brother has a lot to do with this...
Making sense...why share this knowledge?
I'm a fan...but what makes there software superior to the rest?
Did you cash in?
What's the negative if no 10ks are posted?
No doubt, can't stop progress.
As long as it's not in my eye.....lol, just bought more.
Looks like a terrorist Network.
GL...this stock reminds me of the old tv show Flipper.
You missed the BUS....BUS!
After the election the uncertainty in this sector has flooded the minds of investors. Not pump and dump. Any direction that was once in the making has been put on hold. The party is on hold for now.
Bus are you throwing in the towel?
Go back to your trxt trap, your predictions are working well there.
And he does not waver on his word.....I worked for him and he definitely sticks to his word, unfortunately it depends on the time of day. That's his stick and he's great at it. He's a predictable as the weather on Jupiter.
Take in consideration the new administration, not that there going to stop recreational mj but could. The marathon just went to iron man competition.
Agree
True, but mean while you uncertainty in federal reclassification which would open the doors for medical research. Then he would need to address recreational use. This will not happen soon which leads to uncertainty and the market doesn't like uncertainty. Thats why Canada is a better bet at this point. Jmo GL
Hey anything can happen risk stocks. I look at the big picture, risk here or risk in the USA. Both markets are the move, however government supports in Canada and doesn't (yet) in USA. Just keep in mind if you invest here it should be money you can afford to lose. RISK investments can yield big gains and and big losses.
Lol...go Canada!
My guess is green, Canadian stocks are on the move and this is just the beginning. There government supports medical and recreational. Medical research will be needed for the expansion in this new industry. The payback will be big. In USA the foundation is weak due to the fact government does not support it yet. That's why I'm investing more in Canada then USA. JMO. GL
I like the Canadian mj stocks, what's your take on a good medical research company other then gxxh?
Bought 100 k of grnh
This company is going to POP....this week 10%
Aurora Records its Highest Sales Volume Day and Week
VANCOUVER, Nov. 10, 2016 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
CanvasRx Expands Leadership in Cannabis Patient Counseling
Aurora's wholly owned subsidiary, CanvasRx, Canada's largest network of cannabis patient counseling centres, continues to expand its leadership in patient outreach and registration. CanvasRx has now helped over 13,000 patients register with Licensed Producers, including more than 2,500 patients registered with Aurora. This represents growth in patient registration in excess of 30% since being acquired by Aurora in August, 2016. CanvasRx now has 20 locations across Canada, including Edmonton and Calgary. Five more locations are planned to be opened before the end of 2016.
Establishment of Onsite Analytical Laboratory
Aurora has begun taking receipt of the analytical equipment required for the establishment of its onsite laboratory. The equipment includes ultra-performance liquid chromatography, inductively coupled plasma mass spectrometry, and gas chromatography mass spectrometry. Once commissioned and once approved by Health Canada, the laboratory will save Aurora substantial time and money by allowing the Company to perform Health Canada mandated testing in-house. The facility will ensure that testing methodologies are applied consistently and accurately from batch to batch.
Additionally, the on-site lab facilities will accelerate releases by Quality Control of new batches of Aurora products to registered patients, shortening time to market and increasing sales capacity as the Company scales up to full production capacity.
Strong Revenue Generation - Fourth Consecutive Month Exceeding $1 Million
The Company's gross revenues have exceeded $1 million for each of the months of July, August, September and October, 2016. In addition, on November 2, 2016 Aurora processed 1,096 orders and sold 19,745 grams of cannabis, the Company's single highest volume day of sales since beginning commercial operations. The period from October 28 to November 3, 2016 represented Aurora's largest seven-day sales performance ever, with a total of more than 50 kilograms sold.
Significantly Enhanced Cash Position with Strong Balance Sheet
With the recently announced closing of its $25 million convertible debenture, Aurora has significantly increased its current cash position. Aurora now has one of the strongest cash positions in the cannabis sector, with approximately $48 million in unrestricted cash available to execute on all the Company's business strategies. These include funding the Company's consolidated operations through to profitability and positive earnings per share, and the significant expansion of Aurora's production capacity.
Furthermore, with the Company's recent transition to the TSX Venture Exchange and greater access to growth capital, Aurora has leveraged this opportunity and immediately raised cash with limited shareholder dilution. This has enabled the Company to strengthen its balance sheet and improve its debt to equity ratio, through early repayment of its senior secured and high interest debt, and conversion into common shares of its $15 million 10% convertible debentures.
Facility Expansion
Down payments of approximately $2 million have been made to supply partners for the Company's planned 650,000 square foot capacity expansion. Project planning and management teams have been formed and are progressing well with preparations.
Management Commentary
"We continue to fire on all cylinders, reaching more patients, continuing to integrate industry-leading technology, and further building our operational capabilities from a position of unprecedented financial strength," said Terry Booth, CEO. "The strength of our balance sheet provides an exceptional opportunity to continue expanding our leadership position in this rapidly growing medical cannabis market. Furthermore, it provides us with the necessary financial resources, without the need to return to the capital markets, to begin preparing and positioning ourselves for the pending legalization of recreational use in Canada, a market estimated at up to $10 billion per year once mature. These preparations include the expansion of our production capacity through the construction of an additional, very large scale, best-in-class production facility."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the TSX Venture Exchange under the symbol "ACB".
Posted 11/10/16
Establishment of Onsite Analytical Laboratory
Aurora has begun taking receipt of the analytical equipment required for the establishment of its onsite laboratory. The equipment includes ultra-performance liquid chromatography, inductively coupled plasma mass spectrometry, and gas chromatography mass spectrometry. Once commissioned and once approved by Health Canada, the laboratory will save Aurora substantial time and money by allowing the Company to perform Health Canada mandated testing in-house. The facility will ensure that testing methodologies are applied consistently and accurately from batch to.
Not that...my post on a Canadian company that just purchased equipment to test within.
Bad sign here...good info means nothing
Lol....missing...there not one stock you would recommend. Change makes more interest then your investments.
I took a break from USA mj stocks and believe this was an over reaction however a year or so down the road our government has some decisions to make and I don't think they'll be grey on it.
Cana...daaaaa
Government Support has more long term upside
Operational Update: Aurora's CanvasRx Subsidiary Surpasses 13,000 Patients Registered
Nov 10, 2016
OTC Disclosure & News Service
-
Operational Update: Aurora's CanvasRx Subsidiary Surpasses 13,000 Patients Registered
Canada NewsWire
VANCOUVER, Nov. 10, 2016
TSXV: ACB
Aurora Records its Highest Sales Volume Day and Week
VANCOUVER, Nov. 10, 2016 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.
CanvasRx Expands Leadership in Cannabis Patient Counseling
Aurora's wholly owned subsidiary, CanvasRx, Canada's largest network of cannabis patient counseling centres, continues to expand its leadership in patient outreach and registration. CanvasRx has now helped over 13,000 patients register with Licensed Producers, including more than 2,500 patients registered with Aurora. This represents growth in patient registration in excess of 30% since being acquired by Aurora in August, 2016. CanvasRx now has 20 locations across Canada, including Edmonton and Calgary. Five more locations are planned to be opened before the end of 2016.
Establishment of Onsite Analytical Laboratory
Aurora has begun taking receipt of the analytical equipment required for the establishment of its onsite laboratory. The equipment includes ultra-performance liquid chromatography, inductively coupled plasma mass spectrometry, and gas chromatography mass spectrometry. Once commissioned and once approved by Health Canada, the laboratory will save Aurora substantial time and money by allowing the Company to perform Health Canada mandated testing in-house. The facility will ensure that testing methodologies are applied consistently and accurately from batch to batch.
Additionally, the on-site lab facilities will accelerate releases by Quality Control of new batches of Aurora products to registered patients, shortening time to market and increasing sales capacity as the Company scales up to full production capacity.
Strong Revenue Generation - Fourth Consecutive Month Exceeding $1 Million
The Company's gross revenues have exceeded $1 million for each of the months of July, August, September and October, 2016. In addition, on November 2, 2016 Aurora processed 1,096 orders and sold 19,745 grams of cannabis, the Company's single highest volume day of sales since beginning commercial operations. The period from October 28 to November 3, 2016 represented Aurora's largest seven-day sales performance ever, with a total of more than 50 kilograms sold.
Significantly Enhanced Cash Position with Strong Balance Sheet
With the recently announced closing of its $25 million convertible debenture, Aurora has significantly increased its current cash position. Aurora now has one of the strongest cash positions in the cannabis sector, with approximately $48 million in unrestricted cash available to execute on all the Company's business strategies. These include funding the Company's consolidated operations through to profitability and positive earnings per share, and the significant expansion of Aurora's production capacity.
Furthermore, with the Company's recent transition to the TSX Venture Exchange and greater access to growth capital, Aurora has leveraged this opportunity and immediately raised cash with limited shareholder dilution. This has enabled the Company to strengthen its balance sheet and improve its debt to equity ratio, through early repayment of its senior secured and high interest debt, and conversion into common shares of its $15 million 10% convertible debentures.
Facility Expansion
Down payments of approximately $2 million have been made to supply partners for the Company's planned 650,000 square foot capacity expansion. Project planning and management teams have been formed and are progressing well with preparations.
Management Commentary
"We continue to fire on all cylinders, reaching more patients, continuing to integrate industry-leading technology, and further building our operational capabilities from a position of unprecedented financial strength," said Terry Booth, CEO. "The strength of our balance sheet provides an exceptional opportunity to continue expanding our leadership position in this rapidly growing medical cannabis market. Furthermore, it provides us with the necessary financial resources, without the need to return to the capital markets, to begin preparing and positioning ourselves for the pending legalization of recreational use in Canada, a market estimated at up to $10 billion per year once mature. These preparations include the expansion of our production capacity through the construction of an additional, very large scale, best-in-class production facility."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the TSX Venture Exchange under the symbol "ACB".
Ogrmf
Gotcha...sorry GB
He might be but that could change. The people he's surrounding him are not. The Republican Party, Pence, Giuliani, and need not mention my governor Christy. JMO. These people do not want this.
Hi GB, what's your take with the election outcome.
I think in the states business growth risk factors increase, especially with recreational. I don't think it happens next year, but within the next 4 years government mood can change and slow if not stop recreational use. Medical research will not move forward until federal deregulation.
Canada was where I had hoped we were heading. I think Canada will move forward in research and recreational. But research could be the big payback in the near future.
Pre market was up over a dollar....then someone pulled the shoot!